Figure 5
Figure 5. “In vivo MLR” analysis of lymphocytes from NIMAd-exposed versus NIPAd control offspring. Splenocytes were harvested from NIMAd-exposed and NIPAd control mice and labeled with CFSE. CFSE-labeled splenocytes (50 × 106) were injected intravenously into a BDF1 recipient, which is the maternal type in the F1 backcross breeding system. After 3 days, splenocytes and ILN cells were harvested from the BDF1 recipients. (A) Flow cytometric analysis of lymphoproliferation in BDF1 hosts. H2Kd-negative CFSE-labeled splenic lymphocytes found in BDF1 ILNs were gated as shown. Total lymphocyte proliferation from MMc+ mouse NIMAd no. 9 was less than MMcneg NIMAd no. 10 and NIPA control (no. 2). (B) Inverse correlation between the level of MMc and percentage of proliferated responder lymphocytes recovered from BDF1 lymph nodes (n = 22). (C) Gating strategy for H2Kd-negative (donor) CD4+ T cells. (D) Surface TGF-β and (E) intracellular Foxp3 staining of donor CD4+ T cells. NIMAd no. 9–derived CD4+ T cells expressed a higher amount of surface TGF-β staining on nonproliferated CD4+ T cells than NIMAd no. 10 and NIPA control (no. 2). The horizontal line indicates the level of staining with isotype control antibody. (F) Correlation between the level of MMc and percentage of donor CD4+ T cells expressing surface TGF-β (n = 15). The diagonal lines represent the best fit regression lines in panels B and F.

“In vivo MLR” analysis of lymphocytes from NIMAd-exposed versus NIPAd control offspring. Splenocytes were harvested from NIMAd-exposed and NIPAd control mice and labeled with CFSE. CFSE-labeled splenocytes (50 × 106) were injected intravenously into a BDF1 recipient, which is the maternal type in the F1 backcross breeding system. After 3 days, splenocytes and ILN cells were harvested from the BDF1 recipients. (A) Flow cytometric analysis of lymphoproliferation in BDF1 hosts. H2Kd-negative CFSE-labeled splenic lymphocytes found in BDF1 ILNs were gated as shown. Total lymphocyte proliferation from MMc+ mouse NIMAd no. 9 was less than MMcneg NIMAd no. 10 and NIPA control (no. 2). (B) Inverse correlation between the level of MMc and percentage of proliferated responder lymphocytes recovered from BDF1 lymph nodes (n = 22). (C) Gating strategy for H2Kd-negative (donor) CD4+ T cells. (D) Surface TGF-β and (E) intracellular Foxp3 staining of donor CD4+ T cells. NIMAd no. 9–derived CD4+ T cells expressed a higher amount of surface TGF-β staining on nonproliferated CD4+ T cells than NIMAd no. 10 and NIPA control (no. 2). The horizontal line indicates the level of staining with isotype control antibody. (F) Correlation between the level of MMc and percentage of donor CD4+ T cells expressing surface TGF-β (n = 15). The diagonal lines represent the best fit regression lines in panels B and F.

Close Modal

or Create an Account

Close Modal
Close Modal